DERM - Company ID 0001867066
The table below shows Journey Medical Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $18.51M | $15.96M | $17.63M | $15.01M | $13.14M | $14.63M |
| Cost of revenue | $6.14M | $6.22M | - | $4.94M | $4.79M | $5.29M |
| Gross profit | - | - | - | - | - | - |
| R&D | $54.00K | - | $287.00K | - | $39.00K | $842.00K |
Journey Medical Corp reported annual revenue of $61.86M for fiscal year 2025. That is up 10.2% from $56.13M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $44.53M (FY 2020) to $61.86M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $10.89M |
| $10.11M |
| $12.05M |
| $11.88M |
| $10.57M |
| $11.40M |
| Operating income | $456.00K | -$1.49M | -$1.53M | -$2.88M | -$3.32M | -$2.89M |
| Income tax | $15.00K | - | - | $60.00K | - | - |
| Net income | -$312.00K | -$2.23M | -$2.31M | -$3.80M | -$4.07M | -$2.39M |
| EPS (diluted) | -$0.01 | -$0.08 | -$0.09 | -$0.16 | -$0.18 | -$0.12 |